Condition: Primary Open Angle Glaucoma (POAG) · Open-Angle Glaucoma · Glaucoma · Sponsor: Glostrup University Hospital, Copenhagen
The aim of this clinical trial is to investigate whether oral semaglutide can be used to treat open-angle glaucoma. The main question it aims to answer is: Does oral semaglutide safely improve inner retinal function in patients with open-angle glaucoma as measured by the photopic negative response of the electroretinogram. Researchers will compare oral semaglutide to a placebo (a look-alike substance that contains no drug). Participants will: * Take semaglutide or a placebo every day for 6 months. * Visit the clinic 5 times in total for tests and interviews: At baseline (the first day they are included in the study), after 1 month, after 2 months, after 3 months, and after 6 months (the last day they are included in the study).
This description comes directly from the study's public registry record.
Miriam Kolko, MD, PhD · +45 29807667 · miriamk@sund.ku.dk
Anna-Sophie Thein · anna-sophie.thein@sund.ku.dk
Always discuss trial participation with your own doctor first.
| Department of Ophthalmology, Rigshospitalet | Glostrup Municipality, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06792422